https://www.selleckchem.com/pr....oducts/FK-506-(Tacro
The coronavirus pandemic (Covid-19) presents a variety of challenges for ongoing clinical trials, including an inevitably higher rate of missing outcome data, with new and non-standard reasons for missingness. International drug trial guidelines recommend trialists review plans for handling missing data in the conduct and statistical analysis, but clear recommendations are lacking. We present a four-step strategy for handling missing outcome data in the analysis of randomised trials that are ongoing during a pandemic. We con
Like
Comment
Share
